VWM
TGTX icon

Venturi Wealth Management’s TG Therapeutics TGTX Stock Holding History

Venturi Wealth Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505K Hold
9,196
– – 0.02% 370
2026
Q1 		$305K Hold
9,196
– – 0.01% 458
2025
Q4 		$274K Hold
9,196
– – 0.01% 476
2025
Q3 		$332K Buy
9,196
+196
+2% +$6.46K 0.02% 421
2025
Q2 		$324K Hold
9,000
– – 0.02% 404
2025
Q1 		$355K Hold
9,000
– – 0.02% 404
2024
Q4 		$271K Buy
+9,000
New +$258K 0.01% 475

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Venturi Wealth Management's TGTX Position: Q2 2026 in Review

Venturi Wealth Management held its TG Therapeutics (TGTX) position steady in Q2 2026 at 9,196 shares worth $505K. The position accounts for 0.02% of the portfolio, ranked #370.

Venturi Wealth Management first reported a position in TGTX in Q4 2024 and has held it in 7 quarters since. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Venturi Wealth Management held 9,196 shares of TG Therapeutics worth $505K as of Q2 2026.
  • Venturi Wealth Management left its TG Therapeutics share count unchanged in Q2 2026.
  • TG Therapeutics made up 0.02% of Venturi Wealth Management's portfolio in Q2 2026, its #370 holding.
  • Venturi Wealth Management first reported a position in TG Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.